GSA Capital Partners’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-26,143
| Closed | -$104K | – | 1987 |
|
|
2021
Q3 | $104K | Sell |
26,143
-26,606
| -50% | -$106K | 0.01% | 1321 |
|
|
2021
Q2 | $226K | Buy |
+52,749
| New | +$226K | 0.03% | 1124 |
|
|
2020
Q1 | – | Sell |
-56,542
| Closed | -$222K | – | 1814 |
|
|
2019
Q4 | $222K | Buy |
+56,542
| New | +$222K | 0.03% | 1198 |
|
|
2019
Q3 | – | Sell |
-12,565
| Closed | -$116K | – | 1918 |
|
|
2019
Q2 | $116K | Sell |
12,565
-96,327
| -88% | -$889K | 0.01% | 1330 |
|
|
2019
Q1 | $700K | Buy |
108,892
+70,600
| +184% | +$454K | 0.07% | 493 |
|
|
2018
Q4 | $361K | Buy |
+38,292
| New | +$361K | 0.04% | 735 |
|
|
2018
Q3 | – | Sell |
-10,092
| Closed | -$294K | – | 2104 |
|
|
2018
Q2 | $294K | Sell |
10,092
-3,300
| -25% | -$96.1K | 0.01% | 1397 |
|
|
2018
Q1 | $399K | Sell |
13,392
-28,000
| -68% | -$834K | 0.02% | 1179 |
|
|
2017
Q4 | $1.33M | Buy |
41,392
+32,500
| +365% | +$1.05M | 0.08% | 427 |
|
|
2017
Q3 | $309K | Buy |
+8,892
| New | +$309K | 0.02% | 1225 |
|
|
2016
Q3 | – | Sell |
-44,900
| Closed | -$718K | – | 2170 |
|
|
2016
Q2 | $718K | Buy |
44,900
+22,400
| +100% | +$358K | 0.04% | 850 |
|
|
2016
Q1 | $470K | Buy |
+22,500
| New | +$470K | 0.03% | 1058 |
|